<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>生物制药小编 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-29T11:38:41+08:00</updated>
  <subtitle>“新起点，再出发”——生物医药小编与您共同关注生物制药行业热点。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>瑞博生物启动首个小核酸药物的临床研究：乙肝药物RB1016</title>
    <updated>2020-12-29T08:54:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/80PWcoaBcwVCU30z7KckKg</id>
    <link href="https://mp.weixin.qq.com/s/80PWcoaBcwVCU30z7KckKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正式启动！2021年不可多得的细胞基因免疫治疗技术专场盛会有哪些精彩看点？</title>
    <updated>2020-12-29T08:54:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/MKnytH6QAKPm5pTBgnWJzA</id>
    <link href="https://mp.weixin.qq.com/s/MKnytH6QAKPm5pTBgnWJzA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>影响抗体药物ADA（Anti-Drug antibody）产生的因素</title>
    <updated>2020-12-28T09:18:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/VZidrEghK9gCUusOKK1K4g</id>
    <link href="https://mp.weixin.qq.com/s/VZidrEghK9gCUusOKK1K4g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正式启动！2021年不可多得的细胞基因免疫治疗技术专场盛会有哪些精彩看点？</title>
    <updated>2020-12-28T09:18:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/TvagRNonLf8St4xmGWYnGA</id>
    <link href="https://mp.weixin.qq.com/s/TvagRNonLf8St4xmGWYnGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>甘李药业研发CD19/CD22双特异性CAR-T疗法</title>
    <updated>2020-12-26T21:54:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/dAPu4XVVxvH9K94i9iKGGQ</id>
    <link href="https://mp.weixin.qq.com/s/dAPu4XVVxvH9K94i9iKGGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正式启动！2021年不可多得的细胞基因免疫治疗技术专场盛会有哪些精彩看点？</title>
    <updated>2020-12-26T21:54:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/dmUpV0Olx342nhLbvg9fKg</id>
    <link href="https://mp.weixin.qq.com/s/dmUpV0Olx342nhLbvg9fKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>游方和尚专栏 | 药代动力学的重要概念和方法（二_下）：药物的血浆末端半衰期</title>
    <updated>2020-12-25T22:13:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/qhyxb6eVphTLasVMmNxwqA</id>
    <link href="https://mp.weixin.qq.com/s/qhyxb6eVphTLasVMmNxwqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>双旦礼遇，新年钜献！佰傲谷2021年TG-Bio第二届免疫治疗技术大会报名正式开启！</title>
    <updated>2020-12-25T22:13:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/pumlv-v8BxbTeQQLikO1QQ</id>
    <link href="https://mp.weixin.qq.com/s/pumlv-v8BxbTeQQLikO1QQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Bio-Empower智驱未来 | 赋能生物，开启产业数字化蓝图</title>
    <updated>2020-12-25T06:42:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/65yncbDAEHvG3fW2GGJvLQ</id>
    <link href="https://mp.weixin.qq.com/s/65yncbDAEHvG3fW2GGJvLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>4 亿大单背后：赛多利斯与荣昌的二十年</title>
    <updated>2020-12-25T06:42:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/m7zUDYIZjc1J39JONVeCHw</id>
    <link href="https://mp.weixin.qq.com/s/m7zUDYIZjc1J39JONVeCHw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>IRAK4：自身免疫性疾病和肿瘤免疫双料靶点</title>
    <updated>2020-12-24T09:32:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/sxxkP6b4Gc4BTLACqhO-_Q</id>
    <link href="https://mp.weixin.qq.com/s/sxxkP6b4Gc4BTLACqhO-_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康日百奥顺利取得《药品生产许可证》</title>
    <updated>2020-12-22T20:10:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/smOid2YREVPyoNb3Zg5OBQ</id>
    <link href="https://mp.weixin.qq.com/s/smOid2YREVPyoNb3Zg5OBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体内化的实时动态分析及筛选—生物药物发现抗体选择和优化的关键要求</title>
    <updated>2020-12-22T20:10:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/cdxKD2ZUqq9p4gRQTRjnYg</id>
    <link href="https://mp.weixin.qq.com/s/cdxKD2ZUqq9p4gRQTRjnYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>另一种“生物导弹”→ABC</title>
    <updated>2020-12-22T20:10:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/Tgh-C-dqAWSyeLW6191UVw</id>
    <link href="https://mp.weixin.qq.com/s/Tgh-C-dqAWSyeLW6191UVw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>蛋白质降解新技术: 除了火热的PROTAC，还有LYTAC，AUTAC，ATTEC</title>
    <updated>2020-12-21T18:03:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/tiWy5ZCOBJzG85aXvc1LyA</id>
    <link href="https://mp.weixin.qq.com/s/tiWy5ZCOBJzG85aXvc1LyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>分子互作研发利器SPR技术-药典指定亲和力测定技术</title>
    <updated>2020-12-21T18:03:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/imTg6tYNVVWgQ-qEIFXj6w</id>
    <link href="https://mp.weixin.qq.com/s/imTg6tYNVVWgQ-qEIFXj6w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>游方和尚专栏 | 药代动力学的重要概念和方法（二_上）：药物的血浆末端半衰期</title>
    <updated>2020-12-20T12:36:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/D-esK3KngrwVxNJm4Y3pNg</id>
    <link href="https://mp.weixin.qq.com/s/D-esK3KngrwVxNJm4Y3pNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年FDA批准上市的抗癌新药/适应症</title>
    <updated>2020-12-20T12:36:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/JNi5WGSJvBrRGzFV7Mjf3A</id>
    <link href="https://mp.weixin.qq.com/s/JNi5WGSJvBrRGzFV7Mjf3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>c-Met靶点收获之际——盘点多类型药物的开发现状</title>
    <updated>2020-12-19T10:18:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/UJT4IyAMpw4wYULU1AvsUw</id>
    <link href="https://mp.weixin.qq.com/s/UJT4IyAMpw4wYULU1AvsUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>